Hunan Warrant Pharmaceutical Co (SHSE:688799) Total Long-Term Assets: ¥2,133 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688799 Hunan Warrant Pharmaceutical Co Ltd SHSE:688799
84 GF Score
Price ¥45.24
GF Value ¥33.61
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Hunan Warrant Pharmaceutical Co Total Long-Term Assets?

Hunan Warrant Pharmaceutical Co SHSE:688799 +5.31% 84 Total Long-Term Assets is ¥2,133 Mil as of Mar. 2026. GuruFocus rates SHSE:688799 with a GF Score™ of 84/100 and a GF Value™ of ¥33.61 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. Hunan Warrant Pharmaceutical Co's Total Long-Term Assets for the quarter that ended in Mar. 2026 was ¥2,133 Mil.

Hunan Warrant Pharmaceutical Co Total Long-Term Assets Related Terms

Hunan Warrant Pharmaceutical Co Total Long-Term Assets Historical Data

* Premium members only.

The historical data trend for Hunan Warrant Pharmaceutical Co's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hunan Warrant Pharmaceutical Co Total Long-Term Assets Chart

Hunan Warrant Pharmaceutical Co Annual Data
Trend Dec15 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Long-Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 591.56 760.63 827.20 1,026.37 1,877.42

Hunan Warrant Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Long-Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,081.17 1,172.48 1,354.54 1,877.42 2,133.49
SHSE:688799
84GF Score
Hunan Warrant Pharmaceutical Co Ltd SHSE:688799
Total Long-Term Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hunan Warrant Pharmaceutical Co Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.

Frequently Asked Questions Learn more about Total Long-Term Assets →
What does a Total Long-Term Assets of ¥2,133 Mil mean?
Hunan Warrant Pharmaceutical Co (SHSE:688799) has a Total Long-Term Assets of ¥2,133 Mil as of Mar. 2026. Total Long-Term Assets are assets that are expected to be realized in cash, sold or consumed longer than one year. View historical data on Hunan Warrant Pharmaceutical Co and its competitors.
Is Hunan Warrant Pharmaceutical Co's Total Long-Term Assets too high?
Hunan Warrant Pharmaceutical Co's current Total Long-Term Assets is ¥2,133 Mil. Overall, Hunan Warrant Pharmaceutical Co has a GF Score™ of 84/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hunan Warrant Pharmaceutical Co's Total Long-Term Assets compare to ZTS?
Hunan Warrant Pharmaceutical Co's Total Long-Term Assets of ¥2,133 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Long-Term Assets for a Drug Manufacturers company?
A good Total Long-Term Assets depends on the Drug Manufacturers industry context. However, Total Long-Term Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Long-Term Assets mean?
A high Total Long-Term Assets can signal that a stock is expensive relative to its fundamentals. Total Long-Term Assets are assets that are expected to be realized in cash, sold or consumed longer than one year. View historical data on Hunan Warrant Pharmaceutical Co and its competitors. Hunan Warrant Pharmaceutical Co's current Total Long-Term Assets is ¥2,133 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hunan Warrant Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Hunan Warrant Pharmaceutical Co (SHSE:688799) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥33.61, compared to a current price of ¥45.24 — trading 34.6% above its estimated fair value. The current Total Long-Term Assets is ¥2,133 Mil. Hunan Warrant Pharmaceutical Co's overall GF Score™ is 84/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Long-Term Assets calculated?
Total Long-Term Assets is calculated from a company's financial statements. For Hunan Warrant Pharmaceutical Co (SHSE:688799), the current Total Long-Term Assets is ¥2,133 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hunan Warrant Pharmaceutical Co (SHSE:688799) Overvalued in 2026?

Based on GuruFocus' analysis, Hunan Warrant Pharmaceutical Co stock appears to be overvalued. The current stock price of ¥45.24 is trading 34.6% above its estimated GF Value™ of ¥33.61. GuruFocus considers Hunan Warrant Pharmaceutical Co to be Significantly Overvalued.

Key valuation signals for SHSE:688799:

  • Total Long-Term Assets: ¥2,133 Mil
  • GF Value™: ¥33.61 vs. price of ¥45.24 (34.6% above fair value)
  • GF Score™: 84/100 with 7 warning signs

No single metric tells the full story. See the SHSE:688799 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hunan Warrant Pharmaceutical Co Business Description

Address No. 28 Lutian Road, Building C6-C7, Yuelu District, Changsha, CHN, 410006
Hunan Warrant Pharmaceutical Co Ltd is a pharmaceutical manufacturer. It is engaged in the research and development, production and sales of chemical raw materials, chemical medicine preparations and Chinese medicine preparations.
84GF Score

Get the complete analysis for SHSE:688799

Total Long-Term Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥45.24
Price
¥33.61
GF Value